Tala Najdi, Medical Doctor, Hematology-Oncology Fellow at Gustave Roussy shared a post on LinkedIn:
“I’m glad to share with you the result of our meaningful work now published in ctRO: ‘Prophylactic Cranial Irradiation in ES-SCLC: The Ongoing Debate from the Past to the Immunotherapy Era’.
This article explores a clinical dilemma and reflects on how evolving evidence in the immunotherapy era continues to shape our decision-making.
It highlights key considerations when deciding whether to offer prophylactic cranial irradiation (PCI) to patients with extensive-stage small cell lung cancer (ES-SCLC), balancing potential benefits with risks.
I would be very interested to hear your perspectives on this topic.
Thank you Dr Hampig Raphael Kourie for your continuous support. Thank you Dr Fares Azoury, Dr Carine Harmouche Nacouzi, MD, MSc for being part of this. Thank you to my colleagues Antoine Richa, Toufic Zeidan, Mia El Chamieh.”
Title: Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era
Authors: Hampig Raphael Kourie, Tala Najdi, Antoine Richa, Mia Chamieh, Toufic Zeidane, Fares Azoury, Carine Harmouche
Read The Full Article
Other articles about Immunotherapy on OncoDaily.